Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Zhongzhi Pharmaceutical Holdings Limited
  6. Summary
    3737   KYG989611085

ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

(3737)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
1.06 1.04 0.95 0.94 0.96 Last
229000 78000 614000 237000 141000 Volume
-0.93% -1.89% -8.65% -1.05% +2.13% Change
Estimated financial data (e)
Sales 2019 1 342 M 211 M 211 M
Net income 2019 115 M 18,0 M 18,0 M
Net cash position 2019 261 M 40,9 M 40,9 M
P/E ratio 2019 9,37x
Yield 2019 4,19%
Sales 2020 1 604 M 252 M 252 M
Net income 2020 139 M 21,7 M 21,7 M
Net cash position 2020 123 M 19,3 M 19,3 M
P/E ratio 2020 9,99x
Yield 2020 1,87%
Capitalization 703 M 111 M 110 M
EV / Sales 2019 0,53x
EV / Sales 2020 0,66x
Nbr of Employees 3 402
Free-Float 23,5%
More Financials
Company
Zhongzhi Pharmaceutical Holdings Ltd is a China-based investment holding company. The Company is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The Company operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
All news about ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
08/26Zhongzhi Pharmaceutical Holdings Limited Recommends Not to Distribute Any Interim Divid..
CI
08/26Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year End..
CI
04/14ZHONGZHI PHARMACEUTICAL : Annual general meeting for the year ended 31 december 2020 form ..
PU
04/14ZHONGZHI PHARMACEUTICAL : (1) general mandates to repurchase and issue shares (2) re-elect..
PU
04/14Zhongzhi Pharmaceutical Holdings Limited Proposes Not to Distribute Any Dividend At the..
CI
04/07ZHONGZHI PHARMACEUTICAL : Supplemental announcement discloseable transaction construction ..
PU
03/25ZHONGZHI PHARMACEUTICAL : Pharma Awards Factory Construction Contracts to Guangdong Zhengd..
MT
03/25ZHONGZHI PHARMACEUTICAL : Profit Soars 21% in 2020
MT
03/24ZHONGZHI PHARMACEUTICAL : Appoints New CEO, CFO
MT
03/24ZHONGZHI PHARMACEUTICAL : Discloseable transaction construction contracts
PU
03/24ZHONGZHI PHARMACEUTICAL : Change of chief executive and chief financial officer
PU
03/24Zhongzhi Pharmaceutical Holdings Limited Announces Executive Changes
CI
03/24Zhongzhi Pharmaceutical Holdings Limited Announces Change of Chief Financial Officer
CI
03/24Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year End..
CI
2020Zhongzhi Pharmaceutical Holdings Limited Approves an Interim Dividend
CI
More news
News in other languages on ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
08/26Zhongzhi Pharmaceutical Holdings Limited recommande de ne pas distribuer d'acompte sur ..
04/14Zhongzhi Pharmaceutical Holdings Limited propose de ne pas distribuer de dividende à la..
03/25Zhongzhi Pharma attribue des contrats de construction d'usine à Guangdong Zhengdong ; l..
03/25Le bénéfice de Zhongzhi Pharmaceutical grimpe de 21 % en 2020
03/24Zhongzhi Pharmaceutical nomme un nouveau PDG et un nouveau directeur financier
More news
Chart ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
Duration : Period :
Zhongzhi Pharmaceutical Holdings Limited Technical Analysis Chart | 3737 | KYG989611085 | MarketScreener
Technical analysis trends ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Ying Feng Lai Chief Executive Officer & Executive Director
Zhi Tian Lai Chairman
Kwun Wan Ng Independent Non-Executive Director
Kam Wah Wong Independent Non-Executive Director
Dai Han Zhou Independent Non-Executive Director